NovoLog Mix 70/30 is a Subcutaneous Injection, Suspension in the Human Prescription Drug category. It is labeled and distributed by Novo Nordisk. The primary component is Insulin Aspart.
| Product ID | 0169-2200_3fdc375f-3c78-4a91-9bcd-092f51332b41 |
| NDC | 0169-2200 |
| Product Type | Human Prescription Drug |
| Proprietary Name | NovoLog Mix 70/30 |
| Generic Name | Insulin Aspart |
| Dosage Form | Injection, Suspension |
| Route of Administration | SUBCUTANEOUS |
| Marketing Start Date | 2001-11-01 |
| Marketing Category | BLA / |
| Application Number | BLA021172 |
| Labeler Name | Novo Nordisk |
| Substance Name | INSULIN ASPART |
| Active Ingredient Strength | 100 [iU]/mL |
| Pharm Classes | Insulin [CS],Insulin Analog [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2021-07-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0169-2200 | NovoLog Mix 70/30 | insulin aspart |
| 0169-2201 | NovoLog Mix 70/30 | insulin aspart |
| 0169-3685 | NovoLog Mix 70/30 | insulin aspart |
| 0169-3696 | NovoLog Mix 70/30 | insulin aspart |
| 50090-2272 | NovoLog Mix 70/30 | NovoLog Mix 70/30 |
| 50090-2273 | NovoLog Mix 70/30 | NovoLog Mix 70/30 |
| 70518-2119 | NovoLog Mix 70/30 | NovoLog Mix 70/30 |
| 50090-4074 | NovoLog Mix 70/30 | NovoLog Mix 70/30 |
| 0169-2100 | NOVOLOG | insulin aspart |
| 0169-2101 | NOVOLOG | insulin aspart |
| 0169-3303 | NOVOLOG | insulin aspart |
| 0169-6338 | NOVOLOG | insulin aspart |
| 0169-6339 | NOVOLOG | insulin aspart |
| 0169-7501 | NOVOLOG | insulin aspart |
| 50090-1664 | NOVOLOG | insulin aspart |
| 50090-1665 | NovoLog | insulin aspart |
| 50090-1678 | NOVOLOG | insulin aspart |